Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Novel targets, therapies and toxicities in genitourinary cancers

Antibody drug conjugates and FGFR-directed therapies: New toxicities

Date

23 Oct 2023

Session

Novel targets, therapies and toxicities in genitourinary cancers

Topics

Tumour Site

Urothelial Cancer

Presenters

Yohann Loriot

Authors

Y. Loriot

Author affiliations

  • Cancer Medicine Department, Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Novel targets, therapies and toxicities in genitourinary cancers

Resources:

Slides

Webcast

Conclusions and perspectives 

Presenter: Debbie Robbrecht

Session: Novel targets, therapies and toxicities in genitourinary cancers

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.